Study Results: MistGo® Sets a New Standard in Eye Care The results are in! EYE-GO’s recent study involving 22 patients with glaucoma or high eye pressure over 14 days highlights the transformative impact of MistGo® on eye medication delivery. Here’s what we learned: Key findings: 1. Exceptional User-Friendliness: Patients rated MistGo® 9.4/10 for ease of use, compared to 6.6/10 for traditional eye drops. “It was just…puff and done. Incredibly simple to use” 2. Superior Comfort: MistGo® achieved a 9.5/10 comfort rating, surpassing traditional eye drops at 7.2/10. “There was no discomfort at all. Much more comfortable to eye drops”. 3. Minimal Waste, Maximum Precision: Patients reported being significantly less bothered by excess liquid, with MistGo® scoring 9.9/10 vs 5.8/10 for traditional eye drops. 4. Overwhelming Preference: 20 of 22 participants indicated a preference for MistGo® over traditional eye drops. “This will help a lot of people! When will it be on the market?” What’s next? EYE-GO is eager to bring these results to life. If you’re an investor or ophthalmology player passionate about transforming patient outcomes, let’s connect! #EYEGO #MISTGO #Ophthalmology #StudyResults
Hope it comes to the market fast. Patients that depend on eye medication needs this technology.
I'm glad to hear that. I wish you a successful launch. It's about people and health. Every innovation that brings about an improvement in the treatment of diseases is important. Thank you for this good news.
Chief Executive Officer @ EYE-GO A/S | Board member | Advisor
3wWe truly has the best next generation delivery system regarding adherence and compliance